Jundishapur Journal of Microbiology

Published by: Kowsar

Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma

Kamyar Makvandi 1 , Nastaran Ranjbari 2 , * , Manoochehr Makvandi 3 , Ali Ashraf Teimori 3 , Niloofar Neisi 3 , Mojtaba Rasti 1 , Vida Alipour 1 , Mostafa Albokord 1 , Malek Kanani 2 , Ramezan Ahadi 4 and Ala Habibian 3
Authors Information
1 Infectious and Tropical Disease Research Center, Health Research Institute, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pathology, Imam Khomeini hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Department of Nuclear Medicine, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: November 01, 2015, 8 (11); e25726
  • Published Online: November 21, 2015
  • Article Type: Research Article
  • Received: December 10, 2014
  • Revised: April 5, 2015
  • Accepted: May 23, 2015
  • DOI: 10.5812/jjm.25726

To Cite: Makvandi K, Ranjbari N, Makvandi M, Ashraf Teimori A, Neisi N, et al. Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma, Jundishapur J Microbiol. 2015 ; 8(11):e25726. doi: 10.5812/jjm.25726.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood. 2011; 117(6): 1792-8[DOI][PubMed]
  • 2. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009; 49(5 Suppl)-55[DOI][PubMed]
  • 3. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet. 1999; 353(9160): 1253-7[DOI]
  • 4. Rossner MT. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol. 1992; 36(2): 101-17[PubMed]
  • 5. Khaled IAA, Mahmoud OM, Saleh AF, Baioumi EA. Prevalence of HBV genotypes in Egypt among hepatitis patients. J Am Sci. 2010; 6(11): 185-90
  • 6. Couroucé-Pauty AM, Plançon A, Soulier JP. Distribution of HBsAg Subtypes in the World. Vox Sanguinis. 1983; 44(4): 197-211[DOI]
  • 7. Bouffard P, Lamelin JP, Zoulim F, Lepot D, Trepo C. Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection. J Med Virol. 1992; 37(4): 255-62[PubMed]
  • 8. Calmus Y, Marcellin P, Beaurain G, Chatenoud L, Brechot C. Distribution of hepatitis B virus DNA sequences in different peripheral blood mononuclear cell subsets in HBs antigen-positive and negative patients. Eur J Clin Invest. 1994; 24(8): 548-52[PubMed]
  • 9. Malave Lara C, Gorrino MT, Campelo C, Lardelli P, Cisterna R. Detection of hepatitis B virus DNA and determination of surface antigen expression in peripheral blood mononuclear cells from patients with AIDS. Eur J Clin Microbiol Infect Dis. 1994; 13(3): 267-71[PubMed]
  • 10. Yoffe B, Noonan CA, Melnick JL, Hollinger FB. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis. 1986; 153(3): 471-7[PubMed]
  • 11. Baginski I, Chemin I, Bouffard P, Hantz O, Trepo C. Detection of polyadenylated RNA in hepatitis B virus-infected peripheral blood mononuclear cells by polymerase chain reaction. J Infect Dis. 1991; 163(5): 996-1000[PubMed]
  • 12. Roisman FR, Castello A, Fainboim H, Morelli A, Fainboim L. Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol. 1994; 70(2): 99-103[PubMed]
  • 13. Stoll-Becker S, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol. 1997; 71(7): 5399-407[PubMed]
  • 14. Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation. 1990; 49(6): 1155-8[PubMed]
  • 15. Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley A, et al. Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology. 1992; 16(1): 36-41[PubMed]
  • 16. Pontisso P, Vidalino L, Quarta S, Gatta A. Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev. 2008; 8(1): 13-7[DOI][PubMed]
  • 17. Murakami Y, Minami M, Daimon Y, Okanoue T. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. J Med Virol. 2004; 72(2): 203-14[DOI][PubMed]
  • 18. Umeda M, Marusawa H, Seno H, Katsurada A, Nabeshima M, Egawa H, et al. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J Hepatol. 2005; 42(6): 806-12[DOI][PubMed]
  • 19. Pontisso P, Poon MC, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in mononuclear blood cells. BMJ. 1984; 288(6430): 1563-6[DOI]
  • 20. Kang J, Cho JH, Suh CW, Lee DH, Oh HB, Sohn YH, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol. 2011; 90(2): 159-64[DOI][PubMed]
  • 21. Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol. 2008; 80(6): 960-6[DOI][PubMed]
  • 22. Nath A, Agarwal R, Malhotra P, Varma S. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J. 2010; 40(9): 633-41[DOI][PubMed]
  • 23. Sitnik R, Pinho JR, Bertolini DA, Bernardini AP, Da Silva LC, Carrilho FJ. Hepatitis B virus genotypes and precore and core mutants in Brazilian patients. J Clin Microbiol. 2004; 42(6): 2455-60[DOI][PubMed]
  • 24. Fernandez E, Rodrigo L, Garcia S, Riestra S, Blanco C. Hepatitis B surface antigen detection using pooled sera. A cost-benefit analysis. Rev Esp Enferm Dig. 2006; 98(2): 112-21[PubMed]
  • 25. de Souza MM, Barbosa MA, Borges AM, Daher RR, Martins RM, Cardoso D. [Seroprevalence of hepatitis B virus infection in patients with mental problems]. Rev Bras Psiquiatr. 2004; 26(1): 35-8[PubMed]
  • 26. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol. 1987; 61(10): 3030-4[PubMed]
  • 27. Hui CK, Sun J, Au WY, Lie AK, Yueng YH, Zhang HY, et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol. 2005; 42(6): 813-9[DOI][PubMed]
  • 28. Chen MH, Hsiao LT, Chiou TJ, Liu JH, Gau JP, Teng HW, et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol. 2008; 87(6): 475-80[DOI][PubMed]
  • 29. Marcucci F, Spada E, Mele A, Caserta CA, Pulsoni A. The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res. 2012; 2(1): 18-28[PubMed]
  • 30. Eftekhari Y, Kazemi Arababadi M, Hakimi H, Rezazadeh Zarandi E. Common HBV genotype in southeastern Iranian patients. Arch Iran Med. 2010; 13(2): 147-9[PubMed]
  • 31. Anderson LA, Engels EA. Hepatitis C virus infection and non-Hodgkin lymphoma: interesting association or causal relationship? Int J Cancer. 2008; 122(8)[DOI][PubMed]
  • 32. Ozguroglu M, Bilici A, Turna H, Serdengecti S. Reactivation of Hepatitis B Virus Infection with Cytotoxic Therapy in Non-Hodgkin's Lymphoma. Med Oncol. 2004; 21(1): 67-72[DOI]
  • 33. Kim JS, Hahn JS, Park SY, Kim Y, Park IH, Lee CK, et al. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma. Yonsei Med J. 2007; 48(1): 78-89[PubMed]
  • 34. Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, et al. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma. Ann Hematol. 2004; 83(1): 58-60[DOI][PubMed]
  • 35. Jadali Z. Hepatitis C virus cryoglobulinemia and non-hodgkin lymphoma. Hepat Mon. 2012; 12(2): 85-91[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments